当前位置:首页 - 行情中心 - 丸美生物(603983) - 财务分析 - 现金流量表

丸美生物

(603983)

  

流通市值:99.57亿  总市值:99.57亿
流通股本:4.01亿   总股本:4.01亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金898,352,585.353,922,166,113.162,507,857,434.481,795,275,069.67
  收到的税费返还515.56-50,749.8851,130.74
  收到其他与经营活动有关的现金32,046,839.6676,313,507.1550,292,275.8844,247,489.7
  经营活动现金流入小计930,399,940.573,998,479,620.312,558,200,460.241,839,573,690.11
  购买商品、接受劳务支付的现金254,264,870.41,017,504,988.33821,382,359.36596,515,187.7
  支付给职工以及为职工支付的现金83,750,417.21266,436,208.27195,852,784.32131,348,731.75
  支付的各项税费57,691,416.9267,994,938.88195,300,610.67147,798,515.66
  支付其他与经营活动有关的现金497,499,729.382,172,667,082.511,186,791,466.36784,381,420.61
  经营活动现金流出小计893,206,433.893,724,603,217.992,399,327,220.711,660,043,855.72
  经营活动产生的现金流量净额37,193,506.68273,876,402.32158,873,239.53179,529,834.39
二、投资活动产生的现金流量:
  收回投资收到的现金57,270,000140,000,000105,000,000105,000,000
  取得投资收益收到的现金1,002,824.333,771,504.652,884,389.432,862,510.37
  处置固定资产、无形资产和其他长期资产收回的现金净额-24,346.17--
  处置子公司及其他营业单位收到的现金净额110,286.4118,918.4--
  收到的其他与投资活动有关的现金-49,527,54049,467,84049,467,840
  投资活动现金流入小计58,383,110.73193,442,309.22157,352,229.43157,330,350.37
  购建固定资产、无形资产和其他长期资产支付的现金77,560,025.82205,247,767.2177,169,465.9120,365,414.78
  投资支付的现金24,999,854.84302,130,000147,130,000115,000,000
  投资活动现金流出小计102,559,880.66507,377,767.2324,299,465.9235,365,414.78
  投资活动产生的现金流量净额-44,176,769.93-313,935,457.98-166,947,236.47-78,035,064.41
三、筹资活动产生的现金流量:
  吸收投资收到的现金700,000---
  其中:子公司吸收少数股东投资收到的现金700,000---
  收到其他与筹资活动有关的现金121,493,293.331,437,822,791.35440,309,091.9415,388,536.34
  筹资活动现金流入小计122,193,293.331,437,822,791.35440,309,091.9415,388,536.34
  偿还债务支付的现金-150,000,000150,000,000150,000,000
  分配股利、利润或偿付利息支付的现金-301,341,400.93200,672,175.8200,666,388.19
  其中:子公司支付给少数股东的股利、利润-455,984.26--
  支付其他与筹资活动有关的现金135,979,845.261,584,214,907.56472,434,628.5421,884,336.31
  筹资活动现金流出小计135,979,845.262,035,556,308.49823,106,804.3772,550,724.5
  筹资活动产生的现金流量净额-13,786,551.93-597,733,517.14-382,797,712.4-357,162,188.16
四、汇率变动对现金及现金等价物的影响-17,794.29-6,647.4925,235.78124,244.98
五、现金及现金等价物净增加额-20,787,609.47-637,799,220.29-390,846,473.56-255,543,173.2
  加:期初现金及现金等价物余额941,260,789.651,579,060,009.941,579,060,009.941,579,060,009.94
  期末现金及现金等价物余额920,473,180.18941,260,789.651,188,213,536.381,323,516,836.74
补充资料:
  净利润-246,742,825.83-174,712,447.04
  资产减值准备-3,287,597.39-1,349,645.31
  固定资产和投资性房地产折旧-42,043,888.55-15,816,105.8
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-42,043,888.55-15,816,105.8
  无形资产摊销-19,762,865.84-1,866,733.84
  长期待摊费用摊销-973,479.91-6,412,402.73
  处置固定资产、无形资产和其他长期资产的损失--377,398.06--377,398.06
  固定资产报废损失-259,847.08-39,562.75
  公允价值变动损失--432,554.85--587,598.74
  财务费用-3,808,356.01-2,656,560.66
  投资损失--27,553,438.99--2,783,249.38
  递延所得税--16,995,221.31-4,347,474.62
  其中:递延所得税资产减少--18,982,813.59-5,872,785.95
    递延所得税负债增加-1,987,592.28--1,525,311.33
  存货的减少--16,978,963.04--22,795,755.2
  经营性应收项目的减少-54,365,901.07-21,324,624.09
  经营性应付项目的增加--36,548,056.92--22,390,834.6
  其他----428,994.71
  现金的期末余额-941,260,789.65-1,323,516,836.74
  减:现金的期初余额-1,579,060,009.94-1,579,060,009.94
  现金及现金等价物的净增加额--637,799,220.29--255,543,173.2
公告日期2026-04-302026-04-012025-10-312025-08-23
审计意见(境内)标准无保留意见
TOP↑